Drug
Rifaximin (Xifaxan)
Rifaximin (Xifaxan) is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(20%)
Results Posted
200%(2 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_2
1
20%
Ph phase_3
2
40%
Ph early_phase_1
1
20%
Ph phase_4
1
20%
Phase Distribution
1
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(1)
Terminated(2)
Detailed Status
Terminated1
Recruiting1
Completed1
Withdrawn1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 32 (40.0%)
Phase 41 (20.0%)
Trials by Status
terminated120%
recruiting120%
completed120%
withdrawn120%
not_yet_recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
recruitingearly_phase_1
Efficacy and Safety of Rifaximin in Treating MAFLD
NCT07185932
not_yet_recruitingphase_4
Gut Decolonisation With Neomycin/Metronidazole or Rifaximin Before Colon Surgery
NCT07180615
completedphase_3
A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
NCT00269399
terminatedphase_3
A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.
NCT02920242
withdrawnphase_2
Rifaximin Treatment of Papulopustular Rosacea
NCT01359228
Clinical Trials (5)
Showing 5 of 5 trials
NCT07185932Early Phase 1
Efficacy and Safety of Rifaximin in Treating MAFLD
NCT07180615Phase 4
Gut Decolonisation With Neomycin/Metronidazole or Rifaximin Before Colon Surgery
NCT00269399Phase 3
A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
NCT02920242Phase 3
A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.
NCT01359228Phase 2
Rifaximin Treatment of Papulopustular Rosacea
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5